Group purchasing organization Novation put the spotlight on St. Jude Medical (NYSE:STJ) in the latest issue of the GPO’s EuroPCR report, CVWatch.
Group Purchasing Organizations (GPO)
Healthcare group purchasers form global alliance to drive down costs
A team of 5 international healthcare group purchasing organizations, including U.S.-based Novation, joined forces to form the Global Healthcare Procurement Alliance.
The new partnership is committed to "continuing the dialogue and the expansion of the global effort to reduce health care supply chain costs," according to a press release.
GPOs: Novation, Premier tout new supply agreements for wound care and handheld surgical products
Two of the hospital industries leading group purchasing organizations announced a flurry of supply deals with medical device companies for wound care and hand held surgical instruments Thursday.
Group purchaser Novation saves members more than $1B | MassDevice.com On Call
MASSDEVICE ON CALL — Group purchasing organization Novation this week celebrated having saved $1 billion for its members since the company’s founding.
Novation, which is owned by VHA Inc. and the University HealthSystem Consortium, represents more than 25,000 healthcare providers including hospitals, non-acute care centers and academic medical centers.
GPOs: Premier signs new contract with Carestream for imaging systems
Group purchasing organization Premier Healthcare signed a new contract with Carestream to provide diagnostic dental imaging systems to its 86,000-plus membership.
Premier has been offering Carestream imaging systems to its members since 2010, but the new contract extends the deal for another 3 years.
Medical device sales: Why GPOs rule the med-tech world – it’s the data, stupid
There’s ample evidence to suggest that the tip of the medical device industry’s spear is losing its point.
MassDevice.com, along with our channel partners at the Endovascular Forum, recently conducted a poll of endovascular specialists about the influence of medical device company sales reps on their decisions to use a specific device. The results were a bit stark, if you’re in medical device sales.
Novation CEO Jody Hatcher: ‘Ruthlessly focused’ on driving hospital costs down
Medical device companies should take heed of how Novation CEO Jody Hatcher sees the world.
The 45-year-old CEO of the Irving, Texas-based group purchasing organization doesn’t just know their biggest customers. Odds are, he is the biggest customer. Novation, which is owned by VHA Inc. and the University HealthSystem Consortium, represents more than 25,000 healthcare providers, including hospitals, non-acute care centers and academic medical centers.
MassDevice.com +7 | The top 7 med-tech stories for the week of July 16, 2012
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
EXCLUSIVE: Novation CEO looks back on Medtronic split
Few people know what it’s like to lose $2 billion worth of business in a single day, let alone survive that kind of blow and grow in spite of it.
But Novation CEO Jody Hatcher told MassDevice .com recently that he doesn’t harbor any resentment over the February 2011 decision by Medtronic (NYSE:MDT) to spike 5 contracts with the GPO covering cardiovascular and orthopedic products.
Hansen Medical sinks on FDA win for surgical robot | Wall Street Beat
Hansen Medical (NSDQ:HNSN) sank hard on Wall Street today despite announcing a vital FDA win for its Magellan surgical robot.
The device lost 4.8% as of about 3:45 p.m. today, with shares trading around $2.18.
Biomet considers spinning out dental | Wall Street Beat
In a growing trend among device makers, Biomet Inc. announced that it’s exploring strategic options to spin out its 3i dental devices division.
The company is just testing the waters and a split isn’t guaranteed, but if completed the move will follow in some notable footsteps.